Cell Therapy News/Articles, page-901

True @stokdog.

And "bigpharma" knows they can keep their pocketchange in their pockets. MSB big holders won't fold for a piddle.

SI and his close supporters, financially and culturally and personally, will not yield a single share for under $40. Why would they bother?

They are all extremely well off without MSB. Many of us think MSB could go to $100 plus.. The big holders would lose nothing but gain huge by sitting. There will be no TO at less than $50.

Ignore current up and down dribble of SP. It relates ZERO to real value. It's just market manoeuvring. Toolies playing their game, trying to score against the naive and sensitive.

Announcements is first, last, and everything in between, in determining SP. Announcements will provoke Tasly, Amgen, whoever and everywherever to panic. They will be (are) competing for MSB technology. Wait for it. Not long.

And forget about NPV, PE, PEG, EBITDA etc: EMOTIONwill rule for a brief period. Causing multiplication of SP way beyond @ecoool2's and @otherperspective's sober assessments THAT will be the tricky time for us LTH, to decide whether to hold for the science or screw the rainbow-eyed.
I might leave the undoubted upside for the slower to react and sell when my family is cared for. $40 would very comfortably cover me and mine.